Rehabilitation With Personalized Strategies According to Muscle Volume Before Knee Arthroplasty (REPERAGE)

May 16, 2022 updated by: University Hospital, Brest

Personalized Rehabilitation Strategies According to Muscle Volume Before Knee Arthroplasty: a Pilot Study

Preoperative rehabilitation before total knee arthroplasty (TKA) has not been proven to be effective. Latest meta-analyzes do not find any improvement of motor performance during gait 6 months after surgery. However, most of the previous studies did not specifically target muscle atrophy to design rehabilitation protocol. Pre-operative muscle atrophy, although not systematic, is often observed. The preoperative muscles volumes of thigh muscles have been poorly identified and never used to adjust the pre operative rehabilitation strategy.

As part of the "FOLLOWKNEE" (RHU) project, which attempts to implement a personalized management of TKA and its follow-up, this study wants to explore the potential effect of adapted treatment to improve muscle force and muscle volume before TKA.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Terminal stage gonarthrosis with total knee arthroplasty (TKA) indication
  • TKA indicated by the surgeon
  • Body Mass Index < 35
  • Acceptance to realize a preoperative rehabilitation in outpatient setting
  • Adult between 18 and 80 years old
  • Patient affiliated to social security
  • Patient who signed an informed consent

Exclusion Criteria:

  • Functionally uncomfortable osteoarticular illness (disabling pain, functional limitation of joint amplitudes or muscle strength) of controlateral leg.
  • Unable or refusal to consent
  • Contraindication to electrostimulation (skin lesion, nearby implanted metallic material, implanted cardiac or neurologic electrostimulator, intolerance to muscle electrical stimulation)
  • Unstable medical situation preventing the continuous realization of a program of at least 4 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Global rehabilitation
2 hours of daily rehabilitation, 3 days per week during 4 weeks
Patient with knee arthroplasty indication. After clinical assessment and a MRI measurement of muscle volume, patient start a 2 hours daily rehabilitation targeting muscles groups with strengthening and stretching exercises, 3 days per week during 4 weeks.
Experimental: Personalized rehabilitation
2 hours of daily rehabilitation including at least 2 times 20 minutes of electrostimulation on atrophied muscles, 3 days per week during 4 weeks
Patient with knee arthroplasty indication. After clinical assessment and a MRI measurement of muscle volume, patients start a 2 hours daily rehabilitation including 2 times 20 minutes of electrostimulation of atrophied muscles, 3 days per week during 4 weeks.
No Intervention: Classic rehabilitation
40 minutes of rehabilitation, once a week during 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference of isometric strength D0-W4p
Time Frame: Day 0 to Week 4 postoperative
Isometric strength of quadriceps (QS) and hamstring (HS) will be measured on isokinetic bench and the difference between D0 and W4 will be calculated as follows : (QSW4p-QSD0)+(HSW4p-HSD0). Personalized rehabilitation will first be compared to classic rehabilitation and if positive to global rehabilitation.
Day 0 to Week 4 postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference of isometric strength D0-W4
Time Frame: Day 0 to Week 4
Isometric strength of quadriceps (QS) and hamstring (HS) will be measured on isokinetic bench and the difference between D0 and W4 (W4) will be calculated.
Day 0 to Week 4
Difference of isometric strength D0-W12p
Time Frame: Day 0 to Week 12 postoperative
Isometric strength of quadriceps (QS) and hamstring (HS) will be measured on isokinetic bench and the difference between D0 and W12postoperative (W12p) will be calculated.
Day 0 to Week 12 postoperative
Muscles volumes
Time Frame: Day 0, Week 4, Week 2 postoperative
Quadriceps and hamstring volume as well as all muscles volume of each muscles groups will be evaluated in MRI.
Day 0, Week 4, Week 2 postoperative
Walking speed on 10 meters
Time Frame: Day 0, Week 4, Week 4 postoperative, Week 12 postoperative
The patient will be timed when walking 10meters on a graduated corridor. They will be allowed to stop or use a technical help.
Day 0, Week 4, Week 4 postoperative, Week 12 postoperative
Time up and go test (TUG)
Time Frame: Day 0, Week 4, Week 4 postoperative, Week 12 postoperative
The patient must get up from the sitting position and walk three meters from the chair and then retrace his steps (turn 180 degrees) and sit down again. The time that the person puts to this activity is timed by the evaluator.
Day 0, Week 4, Week 4 postoperative, Week 12 postoperative
Western Ontario McMaster Osteoarthritis Index (WOMAC)
Time Frame: Day 0, Week 4, Week 4 postoperative, Week 12 postoperative
WOMAC is a medical scale for hip and osteoarthritic knee consisting of 24 questions scored between 0 and 4. The questions are about pain, joint stiffness and function.
Day 0, Week 4, Week 4 postoperative, Week 12 postoperative
Pain in Analogic Visual Scale (AVS)
Time Frame: Day 0, Week 4, Week 4 postoperative, Week 12 postoperative
The pain during the 5 last days will be evaluated by Analogic Visual Scale. Pain is evaluated on a scale between 0 and 10. 0 is no pain and 10 the worse pain.
Day 0, Week 4, Week 4 postoperative, Week 12 postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olivier REMY-NERIS, Pr, University Hospital of Brest

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2020

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

April 1, 2024

Study Registration Dates

First Submitted

March 19, 2020

First Submitted That Met QC Criteria

March 20, 2020

First Posted (Actual)

March 23, 2020

Study Record Updates

Last Update Posted (Actual)

May 17, 2022

Last Update Submitted That Met QC Criteria

May 16, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 29BRC.19.0154

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected data that underlie results in a publication.

IPD Sharing Time Frame

Data will be available beginning three years and ending fifteen years following the final study report completion.

IPD Sharing Access Criteria

Data access request will be reviewed by the internal committee of Brest University Hospital. Requestor will be required to sign and complete a data access agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty

Clinical Trials on Global rehabilitation program

3
Subscribe